Since its inception in 1994, the Center for Aids Research (CFAR) at Case Western Reserve University (CWRU) has been dedicated to coordinating a constantly-expanding spectrum of AIDS-related activities at CWRU and its primary affiliate, University Hospitals of Cleveland (UH). A productive relationship between the CFAR, the CWRU AIDS Clinical Trials Unit (ACTU) and the UH John T. Carey Special Immunology Unit (SIU) spearheads these efforts, ensuring that the two institutions fulfill their mandates as a center of academic excellence and a provider of patient care of the highest quality, respectively. CFAR development continues to benefit from co-operative and interactive ventures forged with additional CWRU centers in priority areas of mutual interest. These include the Cancer Research Center (CRC - AIDS-related malignancies), Skin Disease Research Center (SDRC - HHV-8 and Kaposi's sarcoma), Tuberculosis Research unit (TBRU - HIV/TB interactions) and Center for Medical Mycology (CMM - opportunistic fungal infections). This sustained effort over the last three years as witnessed a two-fold increase in CFAR membership drawn primarily from 12 departments of CWRU and UH), expansion of its present Funded Research Base (FRB) to approximately $13,000,000 in annual direct costs (covering all NIH-funded programs) and recruitment of clinical and basic research faculty. Organization expansion has involved addition of AIDS-Related Malignancies, Clinical Virology/Mycology and Behavioral Research Working Groups to those of International AIDS, Molecular Virology, Mycobacterial Research and Immunology. Finally, an expanded commitment to international AIDS programs has spawned a request to establish an international Clinical Coordination Facility (ICCF) in addition to those providing state-of-the- art technologies for Cytokine Measurement, Biosafety, Molecular Biology and Clinical Research. Collectively, these initiatives attest to successful development of the CWRU CFAR and provide the appropriate platform for its request for renewed funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036219-10
Application #
6510541
Study Section
Special Emphasis Panel (ZAI1-SCO-A (J1))
Program Officer
Young, Janet M
Project Start
1994-04-01
Project End
2004-03-31
Budget Start
2002-04-01
Budget End
2004-03-31
Support Year
10
Fiscal Year
2002
Total Cost
$1,292,713
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Kityo, Cissy; Makamdop, Krystelle Nganou; Rothenberger, Meghan et al. (2018) Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest 128:2763-2773
Wiredja, Danica D; Tabler, Caroline O; Schlatzer, Daniela M et al. (2018) Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells. Retrovirology 15:44
Oliveira, Vitor H F; Perazzo, Joseph D; Josephson, Richard A et al. (2018) Association Between the 6-Minute Walk Test Distance and Peak Cardiorespiratory Fitness Among People Living with HIV Varies by Fitness Level. J Assoc Nurses AIDS Care 29:775-781
Paparisto, Ermela; Woods, Matthew W; Coleman, Macon D et al. (2018) Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity. J Virol 92:
Llewellyn, George N; Alvarez-Carbonell, David; Chateau, Morgan et al. (2018) HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. J Neurovirol 24:192-203
Longenecker, Chris T; Sullivan, Claire E; Morrison, Justin et al. (2018) The effects of HIV and smoking on aortic and splenic inflammation. AIDS 32:89-94
Tomas, Myreen E; Mana, Thriveen S C; Wilson, Brigid M et al. (2018) Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice. Antimicrob Agents Chemother 62:
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Sahmoudi, Karima; Abbassi, Hassan; Bouklata, Nada et al. (2018) Immune activation and regulatory T cells in Mycobacterium tuberculosis infected lymph nodes. BMC Immunol 19:33
Webel, Allison R; Moore, Shirley M; Longenecker, Chris T et al. (2018) Randomized Controlled Trial of the SystemCHANGE Intervention on Behaviors Related to Cardiovascular Risk in HIV+ Adults. J Acquir Immune Defic Syndr 78:23-33

Showing the most recent 10 out of 539 publications